
Infermedica develops AI for symptom assessment, triage, and care navigation, validated in 27+ peer-reviewed studies. Its Clinical AI Triage guides patients from their first symptom to the right level of care, by chat, voice, or form. Governments, public health systems, insurers, and healthcare providers in 30+ countries use it for digital front doors, call center and nurse triage, and pre-visit intake. Healthdirect Australia uses Infermedica’s clinical decision support in its national symptom checker and nurse helpline, serving 26 million Australians. A peer-reviewed NEJM AI study (2025) found that 55% of callers who intended to go to the emergency department were diverted to a less acute setting, with 46% less overtriage than the previous system. The form-based modality of the Medical Guidance Platform is Class IIb medical device software, CE-marked under Regulation (EU) 2017/745 and registered with the UK MHRA. Infermedica is ISO 13485:2016 and ISO 27001:2022 certified, holds a BSI C5 attestation, and is HIPAA, GDPR, and SOC 2 Type 2 compliant. Infermedica has 100+ customers and partners, including Healthdirect Australia, Techniker Krankenkasse, Allianz Partners, Médis, and Microsoft. Clinical AI Triage is available in 20+ languages and has completed 30M+ health checkups. Infermedica also offers Symptomate, a free symptom checker for individuals, built on the same engine. www.infermedica.com